l-mfa, a Potential Therapeutic Target of Diabetic Nephropathy

StatusFinished
Effective start/end date1/01/16 → 31/12/17

Funding

  • American Heart Association - SouthWest: $140,000.00
View all
View less

Keywords

  • Diabetes, Obesity, & Metabolic Syndrome, Kidney